Skip to main content
Equibles

BTI 6-K

British American Tobacco p.l.c. (BTI)

6-K 2024-10-15 For: 2024-10-15
View Original
Added on April 08, 2026

UNITED STATES

                        SECURITIES AND EXCHANGE COMMISSION

                        Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

October 15, 2024

Commission File Number: 001-38159

BRITISH AMERICAN TOBACCO P.L.C.

(Translation of registrant’s name into English)

Globe House

4 Temple Place

London WC2R 2PG

United Kingdom

                        \(Address of principal executive office\)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒              Form 40-F ☐

This report includes materials as exhibits that have been published and made available by British American Tobacco p.l.c. as of October 15, 2024.

EXHIBIT INDEX

Exhibit Description
Exhibit 1 Press Release entitled “Transaction in own shares” dated October 15, 2024.
Exhibit 2 Press Release entitled “BAT Capital Markets Day” dated October 15, 2024.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

British American Tobacco p.l.c.
By: /s/ Christopher Worlock
Name: Christopher Worlock
Title: Assistant Secretary

Date:  October 15, 2024

Exhibit 1

British American Tobacco p.l.c.

15 October 2024

TRANSACTION IN OWN SHARES

British American Tobacco p.l.c. (the "Company") announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 24 April 2024 it purchased the following number of its ordinary shares of 25 pence each ("shares") from Goldman Sachs International as part of its buyback programme announced on 18 March 2024:

Date of purchase: 14 October 2024
Number of ordinary shares of 25 pence each purchased: 64,650
Highest price paid per share (pence): 2,696.00p
Lowest price paid per share (pence): 2,685.00p
Volume weighted average price paid per share (pence): 2,690.43p

The Company intends to cancel the purchased shares.

Following the purchase and cancellation of these shares, the Company will have 2,213,775,507 ordinary shares in issue (excluding treasury shares) which carry voting rights and will hold 133,271,256 ordinary shares in treasury. This information may be used by shareholders to determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it applies in the UK, a schedule of individual trades carried out by Goldman Sachs International on 14 October 2024 is set out below.

Enquiries:

Investor Relations

Victoria Buxton: +44 (0)20 7845 2012 | [email protected]

Schedule of purchases - aggregate information

Issuer name ISIN Code Transaction date Daily total volume (in number of shares) Daily weighted average price of shares acquired Platform
British American Tobacco p.l.c. GB0002875804 14/10/2024 64,650 2,690.43p LSE
British American Tobacco p.l.c. GB0002875804 14/10/2024 0 0 CHIX
British American Tobacco p.l.c. GB0002875804 14/10/2024 0 0 BATE

Schedule of purchases - individual transactions

Number of shares<br><br> purchased Transaction price<br><br> (per share) Market Time of transaction
250 2691 XLON 08:51:49
50 2691 XLON 09:01:26
270 2691 XLON 09:01:26
1 2691 XLON 09:02:12
120 2691 XLON 09:02:18
256 2691 XLON 09:02:18
224 2692 XLON 09:04:00
276 2692 XLON 09:04:00
669 2692 XLON 09:04:43
100 2693 XLON 09:04:43
1 2692 XLON 09:06:39
284 2692 XLON 09:06:39
88 2691 XLON 09:06:39
91 2691 XLON 09:06:39
55 2691 XLON 09:06:39
13 2691 XLON 09:06:39
226 2691 XLON 09:06:39
250 2691 XLON 09:06:56
298 2691 XLON 09:08:12
250 2690 XLON 09:09:35
133 2691 XLON 09:11:12
525 2691 XLON 09:11:12
405 2692 XLON 09:13:31
429 2691 XLON 09:13:45
349 2691 XLON 09:14:47
456 2690 XLON 09:15:35
288 2690 XLON 09:16:59
267 2689 XLON 09:17:22
408 2689 XLON 09:21:10
274 2688 XLON 09:26:04
263 2689 XLON 09:26:13
271 2689 XLON 09:27:20
262 2688 XLON 09:27:54
268 2687 XLON 09:28:06
250 2686 XLON 09:28:36
273 2685 XLON 09:29:48
507 2687 XLON 09:31:02
311 2689 XLON 09:32:23
293 2688 XLON 09:32:36
352 2688 XLON 09:34:15
361 2687 XLON 09:34:41
292 2688 XLON 09:35:51
337 2687 XLON 09:37:17
315 2687 XLON 09:40:10
271 2688 XLON 09:41:35
264 2687 XLON 09:42:25
257 2690 XLON 09:45:39
251 2689 XLON 09:47:01
276 2688 XLON 09:51:00
256 2688 XLON 09:55:06
119 2687 XLON 09:55:24
140 2687 XLON 09:55:24
275 2687 XLON 09:56:37
368 2687 XLON 09:58:03
340 2688 XLON 10:04:51
323 2687 XLON 10:04:51
433 2686 XLON 10:04:51
131 2689 XLON 10:07:40
865 2689 XLON 10:07:40
768 2688 XLON 10:10:43
214 2688 XLON 10:12:59
5 2688 XLON 10:12:59
634 2689 XLON 10:15:11
268 2688 XLON 10:15:14
425 2688 XLON 10:23:25
231 2688 XLON 10:23:25
212 2687 XLON 10:26:02
547 2687 XLON 10:26:02
62 2688 XLON 10:28:00
218 2688 XLON 10:28:00
9 2688 XLON 10:31:25
1 2688 XLON 10:31:25
3 2688 XLON 10:31:25
7 2688 XLON 10:31:32
3 2688 XLON 10:31:32
285 2688 XLON 10:32:14
18 2688 XLON 10:35:24
3 2688 XLON 10:35:24
37 2688 XLON 10:35:56
193 2688 XLON 10:36:57
251 2687 XLON 10:38:11
215 2688 XLON 10:47:11
200 2688 XLON 10:50:34
253 2688 XLON 10:50:34
243 2687 XLON 10:55:00
174 2687 XLON 10:56:39
108 2689 XLON 11:04:05
851 2689 XLON 11:04:05
941 2691 XLON 11:06:13
20 2691 XLON 11:12:05
918 2691 XLON 11:12:05
929 2691 XLON 11:25:11
969 2691 XLON 11:29:03
760 2691 XLON 11:30:29
943 2690 XLON 11:32:40
78 2689 XLON 11:39:53
852 2689 XLON 11:39:53
867 2689 XLON 11:42:31
70 2690 XLON 11:51:23
923 2690 XLON 11:51:23
300 2689 XLON 11:51:39
395 2690 XLON 11:55:30
57 2690 XLON 11:55:30
203 2690 XLON 11:55:30
42 2690 XLON 11:55:30
261 2690 XLON 11:55:30
721 2690 XLON 11:55:32
231 2689 XLON 11:56:31
334 2688 XLON 11:57:08
61 2687 XLON 11:58:45
60 2687 XLON 11:58:45
50 2687 XLON 11:58:45
15 2687 XLON 11:59:14
217 2687 XLON 11:59:14
210 2688 XLON 12:00:00
18 2688 XLON 12:00:03
16 2688 XLON 12:00:07
53 2688 XLON 12:00:08
23 2688 XLON 12:00:09
104 2688 XLON 12:00:09
976 2689 XLON 12:03:54
51 2688 XLON 12:03:54
249 2688 XLON 12:03:54
300 2690 XLON 12:13:08
463 2690 XLON 12:13:08
1 2690 XLON 12:18:15
759 2690 XLON 12:18:15
206 2691 XLON 12:24:45
292 2691 XLON 12:24:45
929 2692 XLON 12:29:11
925 2694 XLON 12:30:57
934 2693 XLON 12:34:36
302 2692 XLON 12:34:40
192 2692 XLON 12:34:40
457 2692 XLON 12:34:40
92 2691 XLON 12:37:25
940 2693 XLON 12:49:28
971 2692 XLON 12:51:02
925 2693 XLON 13:01:37
199 2692 XLON 13:04:49
26 2692 XLON 13:04:49
742 2692 XLON 13:08:33
59 2693 XLON 13:18:33
213 2693 XLON 13:18:33
101 2693 XLON 13:18:33
71 2693 XLON 13:18:33
52 2693 XLON 13:18:33
436 2693 XLON 13:18:33
7 2693 XLON 13:35:24
340 2693 XLON 13:35:24
593 2693 XLON 13:35:24
946 2692 XLON 13:39:30
980 2692 XLON 13:46:34
210 2694 XLON 13:51:35
327 2694 XLON 13:51:35
415 2694 XLON 13:51:35
148 2694 XLON 13:51:35
676 2695 XLON 13:53:57
120 2695 XLON 13:53:57
346 2695 XLON 13:57:45
123 2695 XLON 13:57:45
148 2695 XLON 13:57:45
185 2695 XLON 13:57:45
963 2694 XLON 13:58:22
58 2693 XLON 13:59:04
1 2693 XLON 13:59:04
920 2693 XLON 13:59:04
955 2692 XLON 14:01:02
996 2691 XLON 14:01:53
116 2690 XLON 14:02:16
841 2690 XLON 14:02:16
898 2689 XLON 14:06:23
943 2692 XLON 14:16:42
941 2691 XLON 14:21:17
34 2691 XLON 14:30:05
393 2691 XLON 14:30:05
777 2690 XLON 14:30:33
713 2689 XLON 14:30:39
258 2690 XLON 14:31:01
1744 2690 XLON 14:31:01
218 2690 XLON 14:31:18
495 2690 XLON 14:31:18
124 2696 XLON 15:02:19
3 2696 XLON 15:02:22
239 2696 XLON 15:02:22
133 2696 XLON 15:02:22
1 2696 XLON 15:02:22
88 2696 XLON 15:04:10
12 2696 XLON 15:04:10
50 2695 XLON 15:06:38

Exhibit 2

15 October 2024

BAT Capital Markets Day

On 16 October 2024, we will host a Capital Markets Day for institutional investors and analysts at our Innovation Centre in Southampton, UK. Chief Executive, Tadeu Marroco, and Chief Financial Officer, Soraya Benchikh, will be joined by the management team and senior leaders from across the Group to provide further detail on our transformation journey.

We are committed to Building a Smokeless World and becoming a predominantly smokeless^1^ business by 2035. By providing smokers with access to a wide range of smokeless products, we can drive forward Tobacco Harm Reduction and, ultimately, make cigarettes a thing of the past.

Our well-established multi-category strategy, global footprint, and deep consumer insights are crucial drivers of this journey. Our latest Innovation Centre in Southampton, opened earlier this year, is home to many of our 1,750 scientists, who deliver the rigorous science and R&D that underpin our New Categories.

This event will demonstrate how BAT’s science, innovation, breadth of capabilities and people can combine to achieve a Smokeless World and deliver long-term sustainable value for all our stakeholders.

On track for full-year 2024 guidance

We remain on track to deliver low-single digit organic revenue and adjusted profit from operations growth in FY24. We will progressively improve our delivery to 3-5% organic revenue growth, and mid-single figure adjusted profit from operations growth, on an organic, constant currency basis^2^ by 2026.

Extrapolating current spot rates^3^, we anticipate currency translation to be a c.5% headwind on FY24 adjusted profit from operations. All other guidance is unchanged.

Event details

Presentations will start at 8:30am on 16 October 2024. There will also be a live webcast on www.bat.com/ir for attendees who wish to join the event virtually. A copy of the presentations, together with a video playback of the webcast, will be made available after the event via the same link, and on our refreshed BAT IR App.

For further information, please contact:

Media Centre

+44 (0) 20 7845 2888 (24 hours) | [email protected] | @BATplc

Investor Relations

Victoria Buxton: +44 (0)20 7845 2012

Amy Chamberlain: +44 (0)20 7845 1124

John Harney: +44 (0)20 7845 1263

[email protected]

Notes:

^1^ Predominantly smokeless refers to our ambition to achieve 50% of Group revenue from our smokeless products by 2035. Smokeless refers to Non-Combustibles, including Vapour products, Heated Products, Modern Oral pouches and Traditional Oral.

^2^ To supplement the Group's results presented in accordance with International Financial Reporting Standards (IFRS), the Group's Management Board, as the chief operating decision maker, reviews certain of its results, including revenue, and adjusted profit from operations, at constant rates of exchange, prior to the impact of businesses sold or held-for-sale in the case of revenue and adjusted profit from operations. Although the Group does not believe that these measures are a substitute for IFRS or other operating measures, the Group does believe that such results excluding the impact of businesses sold or to be held-for-sale provide additional useful information to investors regarding the underlying performance of the business on a comparable basis and in the case of the sale of the Group's businesses in Russia and Belarus, the impact these businesses had on revenue and profit from operations. Accordingly, the organic volume and financial measures appearing in this document should be read in conjunction with the Group's results as reported under IFRS and other operating measures.

^3^ Based on current exchange rates of USD/GBP 1.3075 as at close on 11 October 2024.

Important information

References in this announcement to ‘BAT’, ‘Group’, ‘we’, ‘us’ and ‘our’ when denoting opinion refer to British American Tobacco p.l.c. (BAT PLC) and when denoting business activity refer to BAT Group operating companies, collectively or individually as the case may be. This announcement does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any BAT PLC shares or other securities.

Forward looking statements

This announcement contains certain forward-looking statements, including “forward-looking” statements made within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These statements are often, but not always, made through the use of words or phrases such as “believe,” “anticipate,” “could,” “may,” “would,” “should,” “intend,” “plan,” “potential,” “predict,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy,” “outlook”, “target” and similar expressions. These include statements regarding our intentions, beliefs or current expectations concerning, amongst other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the economic and business circumstances occurring from time to time in the countries and markets in which the Group operates.

In particular, these forward-looking statements include statements regarding (i) our commitment to Building a Smokeless World and becoming a predominantly smokeless business by 2035 and (ii) statements under the heading “On track for full-year 2024 guidance.”

All such forward-looking statements involve estimates and assumptions that are subject to risks, uncertainties and other factors. It is believed that the expectations reflected in this announcement are reasonable but they may be affected by a wide range of variables that could cause actual results and performance to differ materially from those currently anticipated.

Among the key factors that could cause actual results to differ materially from those projected in the forward-looking statements are uncertainties related to the following: the impact of competition from illicit trade; the impact of adverse domestic or international legislation and regulation; the inability to develop, commercialise and deliver the Group's New Categories strategy; the impact of supply chain disruptions; adverse litigation and dispute outcomes and the effect of such outcomes on the Group's financial condition; the impact of significant increases or structural changes in tobacco, nicotine and New Categories related taxes; translational and transactional foreign exchange rate exposure; changes or differences in domestic or international economic or political conditions; the ability to maintain credit ratings and to fund the business under the current capital structure; the impact of serious injury, illness or death in the workplace; adverse decisions by domestic or international regulatory bodies; changes in the market position, businesses, financial condition, results of operations or prospects of the Group; direct or indirect adverse impacts associated with climate change and the move towards a circular economy; and cyber security risks caused by the heightened cyber-threat landscape, and increased digital interactions with consumers, and changes to regulation.

Past performance is no guide to future performance and persons needing advice should consult an independent financial adviser. The forward-looking statements reflect knowledge and information available at the date of preparation of this announcement and BAT undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise. Readers are cautioned not to place undue reliance on such forward-looking statements.

No statement in this announcement is intended to be a profit forecast and no statement in this announcement should be interpreted to mean that earnings per share of BAT PLC for the current or future financial years would necessarily match or exceed the historical published earnings per share of BAT PLC.

Additional information concerning these and other factors can be found in BAT PLC filings with the U.S. Securities and Exchange Commission (SEC), including the Annual Report on Form 20-F for the financial year ended December 31, 2023 and Current Reports on Form 6-K, which may be obtained free of charge at the SEC’s website, http://www.sec.gov, and at the British American Tobacco website, http://www.bat.com.

Search and read filings like this one from Claude or ChatGPT with the SEC filings MCP server →